Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molecular Partners Ag (MOLN) Treasury Shares (2022 - 2024)

Historic Treasury Shares for Molecular Partners Ag (MOLN) over the last 4 years, with Q3 2025 value amounting to -$1411.3.

  • Molecular Partners Ag's Treasury Shares fell 2464.56% to -$1411.3 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1411.3, marking a year-over-year decrease of 2464.56%. This contributed to the annual value of -$1115.1 for FY2024, which is 10010.08% down from last year.
  • As of Q3 2025, Molecular Partners Ag's Treasury Shares stood at -$1411.3, which was down 2464.56% from -$1361.3 recorded in Q2 2025.
  • In the past 5 years, Molecular Partners Ag's Treasury Shares ranged from a high of $1.1 million in Q4 2023 and a low of -$1.1 million during Q2 2023
  • Moreover, its 4-year median value for Treasury Shares was -$1119.8 (2024), whereas its average is -$4770.6.
  • As far as peak fluctuations go, Molecular Partners Ag's Treasury Shares tumbled by 10010.13% in 2024, and later skyrocketed by 9987.45% in 2025.
  • Molecular Partners Ag's Treasury Shares (Quarter) stood at $1.0 million in 2022, then grew by 8.61% to $1.1 million in 2023, then plummeted by 100.1% to -$1119.8 in 2024, then dropped by 26.03% to -$1411.3 in 2025.
  • Its last three reported values are -$1411.3 in Q3 2025, -$1361.3 for Q2 2025, and -$1091.1 during Q1 2025.